...
首页> 外文期刊>Journal of mass spectrometry: JMS >The development and assessment of highthroughput mass spectrometry-based methods for the quantification of a nanoparticle drug delivery agent in cellular lysate
【24h】

The development and assessment of highthroughput mass spectrometry-based methods for the quantification of a nanoparticle drug delivery agent in cellular lysate

机译:基于高通量质谱的定量方法用于细胞裂解物中纳米药物递送剂的开发和评估

获取原文
获取原文并翻译 | 示例
           

摘要

The safe use of lipid-based drug delivery agents requires fast and sensitive qualitative and quantitative assessment of their cellular interactions. Many mass spectrometry (MS) based analytical platforms can achieve such task with varying capabilities. Therefore, four novel high-throughput MS-based quantitative methods were evaluated for the analysis of a small organic gene delivery agent: N,N-bis(dimethylhexadecyl)-1,3-propane-diammonium dibromide (G16-3). Analysis utilized MS instruments that detect analytes using low-resolution tandem MS (MS/MS) analysis (i.e. QTRAP or linear ion trap in this work) or high-resolution MS analysis (i.e. time of flight (ToF) or Orbitrap). Our results indicate that the validated fast chromatography (FC)-QTRAP-MS/ MS, FC- LTQ-Orbitrap-MS, desorption electrospray ionization-collision-induced dissociation (CID)-MS/MS and matrix assisted laser desorption ionization-ToF/ToF-MS MS methods were superior in the area of method development and sample analysis time to a previously developed liquid chromatography (LC)-CID-MS/MS. To our knowledge, this is the first evaluation of the abilities of five MS-based quantitative methods that target a single pharmaceutical analyte. Our findings indicate that, in comparison to conventional LC-CID-MS/MS, the new MS-based methods resulted in a (1) substantial reduction in the analysis time, (2) reduction in the time required formethod development and (3) production of either superior or comparable quantitative data. The four new high-throughputMSmethods, therefore, were faster,more efficient and less expensive than a conventional LC-CID-MS/MS for the quantification of the G16-3 analyte within tissue culture. When applied to cellular lysate, no significant change in the concentration of G16-3 gemini surfactant within PAM212 cells was observed between 5 and 53 h, suggesting the absence of any metabolism/excretion from PAM212 cells.
机译:安全使用基于脂质的药物递送剂需要对其细胞相互作用进行快速,灵敏的定性和定量评估。许多基于质谱(MS)的分析平台都可以通过各种功能来完成此类任务。因此,评估了四种新颖的基于MS的高通量定量方法,用于分析小型有机基因传递剂:N,N-双(二甲基十六烷基)-1,3-丙烷-二溴化二铵(G16-3)。分析利用MS仪器通过低分辨率串联MS(MS / MS)分析(即这项工作中的QTRAP或线性离子阱)或高分辨率MS分析(即飞行时间(ToF)或Orbitrap)来检测分析物。我们的结果表明,经过验证的快速色谱(FC)-QTRAP-MS / MS,FC-LTQ-Orbitrap-MS,解吸电喷雾电离-碰撞诱导解离(CID)-MS / MS和基质辅助激光解吸电离-ToF / ToF-MS MS方法在方法开发和样品分析时间方面优于以前开发的液相色谱(LC)-CID-MS / MS。据我们所知,这是对针对单一药物分析物的五种基于质谱的定量方法的能力的首次评估。我们的发现表明,与传统的LC-CID-MS / MS相比,基于MS的新方法导致(1)大大减少了分析时间,(2)减少了方法开发所需的时间,以及(3)产生优质或可比的定量数据。因此,四种新的高通量质谱方法比常规LC-CID-MS / MS更快,更高效且更便宜,可用于定量组织培养物中的G16-3分析物。当应用于细胞裂解液时,在5到53 h之间,未观察到PAM212细胞内G16-3双子表面活性剂浓度的显着变化,表明PAM212细胞不存在任何新陈代谢/分泌。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号